Shanghai Pharmaceuticals Holding Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Pharmaceuticals Holding has a total shareholder equity of CN¥80.3B and total debt of CN¥49.8B, which brings its debt-to-equity ratio to 62%. Its total assets and total liabilities are CN¥212.0B and CN¥131.6B respectively. Shanghai Pharmaceuticals Holding's EBIT is CN¥8.6B making its interest coverage ratio 6. It has cash and short-term investments of CN¥40.7B.
Key information
62.0%
Debt to equity ratio
CN¥49.76b
Debt
Interest coverage ratio | 6x |
Cash | CN¥40.67b |
Equity | CN¥80.33b |
Total liabilities | CN¥131.65b |
Total assets | CN¥211.97b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SHPM.Y's short term assets (CN¥162.4B) exceed its short term liabilities (CN¥122.4B).
Long Term Liabilities: SHPM.Y's short term assets (CN¥162.4B) exceed its long term liabilities (CN¥9.3B).
Debt to Equity History and Analysis
Debt Level: SHPM.Y's net debt to equity ratio (11.3%) is considered satisfactory.
Reducing Debt: SHPM.Y's debt to equity ratio has reduced from 68.5% to 62% over the past 5 years.
Debt Coverage: SHPM.Y's debt is not well covered by operating cash flow (10.5%).
Interest Coverage: SHPM.Y's interest payments on its debt are well covered by EBIT (6x coverage).